Larimar Therapeutics, Inc.
May 21, 2024 - by Joey Ramson
$LRMR which has been trading in a range between about $7 – $8.50 in the month of May, is up today after the FDA had removed a partial clinical hold on Larimar’s nomlabofusp clinical program yesterday after the close.
